MedTrace Logo

18F-NaF-PET for Identification of TCFA

NCT02388412 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2016-02-23

No results posted yet for this study

Summary

Recently, positron emission tomography(PET) using 18F-Sodium fluoride (NaF) showed promising results for detecting vulnerable plaques in some pilot studies.

In this study, the investigators will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque, diagnosed by optical coherence tomography (OCT).

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Bon-Kwon Bon-Kwon, MD, PhD · Seoul National University Hospital

  • Paeng Jin Cheol, MD, PhD · Seoul National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-03-31
Completion
2018-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388412 on ClinicalTrials.gov